ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Climb 13.2% – Still a Buy?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares shot up 13.2% during mid-day trading on Wednesday. The stock traded as high as $12.49 and last traded at $12.21. 160,588 shares were traded during mid-day trading, a decline of 27% from the average session volume of 220,943 shares. The stock had previously closed at $10.79.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CHRN shares. Compass Point initiated coverage on ChronoScale Corporation Common Stock in a research note on Friday, October 16th. They issued a “buy” rating and a $25.00 price objective on the stock. Weiss Ratings lowered ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday, October 23rd. Finally, Northland Securities started coverage on ChronoScale Corporation Common Stock in a report on Friday, September 18th. They issued an “outperform” rating and a $32.00 price target for the company. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, ChronoScale Corporation Common Stock currently has an average rating of “Hold” and an average target price of $21.00.

ChronoScale Corporation Common Stock Stock Performance

The firm has a fifty day moving average of $17.04 and a 200-day moving average of $16.12. The firm has a market cap of $1.56 billion, a P/E ratio of -2.48 and a beta of 1.12. The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.02.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last announced its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) EPS for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. The firm had revenue of $41.48 million during the quarter. Research analysts predict that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current fiscal year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.